Patients aged 18 years and older with relapsed or refractory FLT3 mutated acute myeloid leukemia

1 total trials

Filter these 1 trials by phase, country, sponsor and more.

Open in Search →

FILOAML-RR-01-OGILAR: Open-label, phase 2 study investigating the efficacy and safety of the addition of oral-azacitidine to salvage treatme … Recruitment ended

2022-501372-25-00 4 2024-01-10

Showing 1–1 of 1 trials